Completed
Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
NCT03881696
- Conditions
- Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +5 more
- Locations
-
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology Little Rock, Arkansas, United States
- Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research Stanford, California, United States
- National Jewish Health: Division of Pediatric Allergy and Clinical Immunology Denver, Colorado, United States
- Emory University School of Medicine: Children's Healthcare of Atlanta Pediatrics Atlanta, Georgia, United States